HCA Healthcare is trading sharply lower after reporting first-quarter 2026 results that disappointed on a key profitability metric: adjusted EBITDA missed expectations, overshadowing results that were otherwise closer to consensus. The selloff is being amplified by investor concern that profitability and volume trends did not deliver the typical seasonal lift expected in the first quarter, even as the company reiterated its full-year 2026 outlook. (financialcontent.com)

On the earnings call, management highlighted meaningful headwinds tied to the health insurance exchanges, including an estimated ~15% decline in same-facility exchange equivalent admissions versus the prior-year quarter and an estimated ~$150 million adjusted EBITDA impact in 2026 versus the prior-year period. Separately, management discussed unusual volume dynamics in Q1, including a steep year-over-year decline in respiratory-related activity, which weighed on emergency room visits and admissions comparisons. (fool.com)

HCA reiterated its full-year 2026 outlook, including EPS of $29.10 to $31.50 and revenue of $76.5 billion to $80.0 billion, but the market reaction suggests investors are discounting a higher risk that volume mix and margin performance lag what’s needed to hit the mid-to-high end of guidance. The next key focus is whether volumes normalize in Q2 and whether exchange-related pressure persists or stabilizes as the year progresses. (wtop.com)